Thermosensitive Chitin Sponge Sustained-Release System
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing local anesthetic and analgesic drugs have a short action time, requiring frequent administration and posing risks of systemic side effects and complications such as respiratory depression and addiction. Current sustained-release systems, like microspheres and liposomes, face issues with burst drug release, instability, and compatibility concerns.
Innovation Solution
A thermosensitive modified chitin sponge drug-loaded implanted sustained-release system is developed, comprising a spongy matrix of thermosensitive modified chitin polymers and local anesthetic or anti-inflammatory drugs. This system is designed to provide long-acting local anesthesia and analgesia, with a gel transition temperature suitable for slow drug release at body temperature.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of moving object
If local anesthetic and analgesic drugs are administered frequently to prolong analgesia time, then the duration of action is improved, but the risk of systemic side effects and complications increases
Solution Approach 1:
The patent divides the drug delivery system into a porous sponge matrix that physically contains and releases drug molecules gradually. This segmentation of the drug delivery mechanism allows prolonged analgesia time without requiring frequent administrations, thereby reducing systemic side effects while maintaining effective pain management.
Solution Approach 2:
The patent incorporates a catheter implantation procedure during the initial surgical phase to establish a drug delivery pathway. This preliminary action enables sustained local anesthetic and analgesic drug release over extended periods, eliminating the need for repeated administrations and reducing cumulative systemic exposure and associated complications.
2Duration of action of moving object
If catheter implantation is used to prolong analgesia effect, then the duration of action is improved, but the device complexity and risk of complications increase
Solution Approach 1:
The patent extracts the drug delivery function from complex external catheter systems and integrates it directly into the surgical site through implantable porous sponge matrices. This extraction simplifies the overall system by eliminating the need for external pumps, control mechanisms, and complex catheter configurations, while still achieving prolonged analgesia through the sponge's inherent porous structure that enables sustained drug release.
Solution Approach 2:
The patent employs disposable porous sponge matrices that are implanted during surgery and allow gradual drug release over their service life. These single-use sponges eliminate the need for expensive, complex, and maintainable catheter systems, reducing device complexity and associated risks while providing sustained pain management throughout the recovery period.
3Duration of action of moving object
If repeated administration of analgesic drugs is performed, then the analgesia duration is improved, but the frequency of operation and patient burden increase
Solution Approach 1:
The patent establishes continuous drug release from the porous sponge matrix throughout the recovery period. The sponge's porous structure enables sustained diffusion of anesthetic and analgesic molecules into surrounding tissues, providing uninterrupted pain management without requiring repeated administrations. This continuous action eliminates the burden of frequent operations while maintaining effective analgesia throughout the healing process.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system achieves a prolonged analgesia time, with an effective blockade time 3-8 times longer than traditional ropivacaine hydrochloride solutions, while minimizing systemic side effects and improving biocompatibility and safety. The method is simple, non-toxic, and cost-effective, with potential for large-scale production and clinical application.
Implementation Method 1
a gel transition temperature suitable for slow drug release at body temperature
Data Source
AI summary
The present invention relates to a thermosensitive modified chitin sponge drug-loaded implanted sustained-release system, preparation method therefore, and use thereof. The system comprises the following components: a spongy matrix, the matrix comprising at least one thermosensitive modified chitin polymer, and at least one drug, the drug being a local anesthetic and analgesic drug and/or an anti-inflammatory and antibacterial drug, and the drug being uniformly dispersed in the matrix. All ingredients of the thermosensitive modified chitin sponge drug-loaded implanted sustained-release system have good biodegradability, biocompatibility and bioactivity, and high safety. The system provides drug sustained-release and long-lasting effect, solving the problems that the existing local anesthetic drugs have a short action time. The system may promote wound healing, being easy to store and ship, convenient to use directly, which has great potential in clinical application.